The Continuing Influence of PTAB Proceedings on Bio/Pharma Litigation (Live MBHB Webinar)

Tues., September 19, 2017 | 10:00-11:15 a.m. CT | Live MBHB Webinar via WebEx

Since becoming available nearly 5 years ago, inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB) have become an increasingly popular mechanism to challenge bio/pharma patents. Both petitioners and patent owners can learn lessons from the hundreds of IPR petitions that have been filed challenging bio/pharma patents.

Join us as we discuss the following topics:

  • A look at who is using PTAB proceedings to challenge bio/pharma patents;
  • An analysis of how PTAB proceedings are impacting ANDA and biosimilar litigations;
  • A review of how bio/pharma patents have fared before the PTAB;
  • A discussion of strategies for petitioners and patent owners in IPRs challenging bio/pharma patents; and
  • A discussion of how the Supreme Court’s decision to grant cert in Oil States Energy Services will impact PTAB invalidity proceedings in the bio/pharma space

 

Presenter(s):

 MBHB partners Alison Baldwin and Paula Fritsch, Ph.D.

 

Access an archived audio version of this webinar here

NOTE: MCLE credit is not available for this archived recording.

McDonnell Boehnen Hulbert & Berghoff LLP is committed to educating clients and friends of the firm with respect to significant developments and trends in the areas of intellectual property law.

Search by Type
Menu
Menu